Introgen Anticipates Completion Of Advexin Rolling BLA Submission In 2007
This article was originally published in The Pink Sheet Daily
Executive Summary
Biologic may have synergistic effects with ImClone’s Erbitux and Genentech’s Avastin, firm tells “The Pink Sheet” DAILY.